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452 Am J PBackground: The activity patterns of older adults include more light/mild-intensity or “non-
exercise” activity and less moderate- to vigorous-intensity activity. The health beneﬁts of this type of
activity pattern remain unclear.
Purpose: To examine dose–response associations between physical activity and survival using
time-varying analysis to understand the importance of “non-exercise” activity for survival in older
adults.
Methods: Participants (N¼10,426) were drawn from The English Longitudinal Study of Ageing, a
representative sample of men and women agedZ50 years living in England. Participant data were
linked with death records from the National Health Service registries from 2002 to 2011. Analyses
were conducted in 2013. Cox proportional hazards models were used to estimate the risk of death
according to time-varying estimates of physical activity.
Results: Over an average follow-up of 7.8 years (median follow-up, 8.5 years), there were 1,896
deaths. In models adjusted for comorbidities, psychosocial factors, smoking, and obesity, there was a
dose–response association between time-varying physical activity and mortality, with the greatest
survival beneﬁt in vigorously active participants. However, participating in mild (“non-exercise”)-
intensity physical activity was also associated with a lower risk of all-cause mortality (hazard ratio
[HR]¼0.76, 95% CI¼0.69, 0.83); cardiovascular mortality (HR¼0.74, 95% CI¼0.64, 0.85); and
death by other causes (HR¼0.67, 95% CI¼0.58, 0.78). Time-varying models produced stronger,
more robust estimates than models using a single measurement of physical activity at baseline.
Conclusions: Older adults gain health beneﬁts from participating in regular “non-exercise”
physical activity, although the greatest beneﬁts are observed for more vigorous activity.
(Am J Prev Med 2014;47(4):452–460) & 2014 American Journal of Preventive Medicine
Open access under CC BY-NC-ND license.IntroductionEvidence
1–3 suggests that regular physical activity
(PA) is among the most important lifestyle factors
for the maintenance of health. Inactivity ranks
alongside tobacco, alcohol, and obesity as a leading cause
of reduced healthy life expectancy.4 Despite the impor-
tance of PA for health, there remains a paucity of
evidence on the thresholds and patterns of PA necessary
for health beneﬁts in older populations. Current guide-
lines on PA for the elderly are largely based on data from
the general population and recommend 150 minutes per
week of moderate-intensity activity, 75 minutes per weekartment of Epidemiology and Public Health, University
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Open access uof vigorous activity, or a combination of the two.1
However, older participants are likely to accrue PA of
mild or “non-exercise” intensity and the majority of the
elderly population do not meet the current PA
guidelines.5,6
Several studies7–15 have shown beneﬁcial effects of PA
on survival in elderly cohorts, although owing to the
differences in PA assessment/thresholds across studies, it
is challenging to make direct comparisons on dose–
response effects. For example, in a study7 of people aged
70–88 years, being active was deﬁned as taking part in at
least 4 hours per week of PA, whereas others have
categorized PA according to self-rated intensity of
activity12,14 or total PA energy expenditure.13,15
Some evidence12,14 suggests that survival beneﬁts can
be achieved even at low levels of PA, although further
work in large representative samples of the community is
required to conﬁrm these ﬁndings. Given the barriers to
undertaking vigorous exercise, it is important to examinerican Journal of Preventive Medicine  Published by Elsevier Inc.
nder CC BY-NC-ND license.
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lighter “non-exercise” PA into their daily lives.
The aim of this study was to examine the prospective
dose–response associations between PA and survival in a
large representative community-dwelling sample of
adults aged 50 years and older at baseline. Further, we
aimed to explore whether the dose–response association
differed between younger (ageo70 years) and older (age
Z70 years) participants. To account for individual
variation in PA over time, we made full use of successive
assessments of PA by using a time-varying model. This is
particularly relevant because many previous studies16
have relied on PAmeasures from a single point (baseline)
in time that might underestimate the true effect of PA on
mortality by not accounting for changes in PA over
follow-up.
Methods
Study Sample and Procedures
Participants were drawn from the English Longitudinal Study of
Ageing (ELSA), an ongoing panel study that contains a nationally
representative sample of the English population living in house-
holds.17 The baseline ELSA cohort consists of men and women
born on or before February 29, 1952. The ELSA sample was
recruited from households that had previously participated in the
Health Survey for England (HSE) in 1998, 1999, or 2001. HSE
recruits participants using multistage, stratiﬁed probability sam-
pling with postcode sectors selected at the ﬁrst stage and household
addresses selected at the second stage.
Interviews at baseline (2002–2003) were carried out with 11,391
individuals (5,186 men and 6,205 women); the overall response
rate was 70% at the household level and 67% at the individual level.
After the baseline interview, follow-up interviews took place at
regular 2-year intervals in 2004–2005, 2006–2007, 2008–2009, and
2010–2011 and health examinations in 2004–2005 and 2008–2009.
Analyses were conducted in 2013. Our analytic sample com-
prised 10,426 individuals, after the exclusion of participants who
had not consented for the mortality data linkage and those with
missing baseline values in any of the variables used in the analysis.
Participants gave full informed consent to participate in the study,
and ethical approval was obtained from the National Research
Ethics Committee.
Physical Activity Assessment
Self-reported PA data were collected at baseline and all follow-up
interviews using three questions on the frequency of participation
in vigorous, moderate, and mild physical activities (more than
once per week, once per week, one to three times per month, or
hardly ever). Before answering, participants were shown examples
of activities on a card to help them interpret different PA
intensities.
Examples of mild activities included laundry and home repairs;
moderate-intensity activity included gardening, cleaning the car,
walking at moderate pace, dancing, and ﬂoor or stretching
exercises; and vigorous intensity included running/jogging,October 2014swimming, cycling, aerobics/gym workout, tennis, and digging
with a spade. PA was further categorized into four groups, as
previously described18: inactive (no activity on a weekly basis);
only mild activity at least once a week; at least moderate but no
vigorous activity at least once a week; and any vigorous activity at
least once a week. The PA questions were repeated every 2 years
through follow-up, enabling assessment of changes in PA levels
over time.
We used successive measurements of PA from the baseline and
ﬁrst three follow-up interviews (2002–2008) to construct a time-
varying PA variable that was the main predictor in our analysis.
The time-varying PA variable did not include PA data from the
fourth follow-up interview (2010–2011) because that survey was
completed in June 2011 and causes of death data were available up
to February 2011. The physical activity measure has demonstrated
excellent convergent validity in grading a plethora of psychosocial,
physical, and biochemical risk factors.18–20
Mortality Follow-Up
Individual participant data were linked with death records from
National Health Service registries for all consenting respondents
(96.5% of the sample). Diagnoses for primary cause of death were
recorded using the ICD-10. ICD-10 codes from I00 to I99 were
used to classify cardiovascular deaths and ICD-10 codes from C00
to C97 to classify cancer deaths. Deaths were classiﬁed as “other” if
not arising from causes related to cardiovascular disease (CVD) or
cancer.
Covariates
Age, gender, marital status, and socioeconomic position (SEP) (i.e.,
education and household wealth) were measured. A binary
variable (yes/no) was derived for each of the following self-
reported doctor-diagnosed chronic diseases: hypertension, diabe-
tes, heart disease, stroke, cancer, chronic obstructive pulmonary
disease, and nervous and psychiatric problems. Smoking (current,
previous, or non-smoker) and elevated depressive symptoms
(deﬁned as a score of Z4 on the eight-item Centre of Epidemio-
logical Studies Depression [CES-D] scale21,22) were also assessed.
Nurses collected anthropometric data (weight, height, waist
circumference) during health examinations. Body weight was
measured using Tanita electronic scales (Tokyo, Japan) without
shoes and in light clothing, and height was measured using a
stadiometer. BMI was calculated using the standard formula
(weight [kilograms]/height [meters] squared). We categorized
BMI into the following categories: o18.5, Z18.5 to o25, Z25
to o30, Z30, and missing.
Waist circumference was recorded twice midway between the
iliac crest and lower rib using a measuring tape. An average of the
ﬁrst two measurements was used provided these differed by no
more than 3 cm; otherwise, a third reading was taken and the two
closest results were used. We derived a variable of waist circum-
ference with the following categories: o94 cm, Z94 cm, Z102
cm, and missing (in men) and o80 cm, Z80 cm, Z88 cm, and
missing (in women).
We used multiple measurements of chronic diseases, elevated
depressive symptoms, and smoking from the baseline and the
ﬁrst three follow-up interviews to derive time-varying variables
that were used as covariates in our analysis. We also derived
Hamer et al / Am J Prev Med 2014;47(4):452–460454time-varying BMI and waist circumference variables with the use
of two measurements of BMI and waist circumference from the
ELSA health examinations and one measurement of BMI and
waist circumference from the HSE that was available for the ELSA
respondents.Statistical Analysis
We used Cox proportional hazards regression models to examine
associations between PA and death. Months were the time scale for
the follow-up, and for participants with no record of an event, the
data were censored at February 2011. The proportional hazards
assumption was examined using plots of the Nelson–Aalen
cumulative hazard estimates. Because we aimed to explore whether
the association between PA and survival varied between younger
and older participants, we performed subgroup analyses according
to two age categories, 50–69 years and Z70 years.
We estimated unadjusted models that were sequentially
adjusted for age, then gender and marital status, then SEP and
time-varying chronic diseases. The fully adjusted models were
additionally adjusted for time-varying smoking, elevated depres-
sive symptoms, BMI, and waist circumference. For comparison
reasons, in supplementary analyses, we estimated the same models
using only the baseline measurements of PA and covariates.
Further, to ascertain that the association between PA and
mortality was not confounded by physical disability, we also
estimated the fully adjusted model only for participants who
reported no mobility limitations at baseline. All analyses were
conducted using SPSS, version 20 (SPSS Inc., Chicago IL).Results
Participants deﬁned as physically inactive were older, less
likely to be married, less educated and poorer, and had
higher prevalence of depressive symptoms, obesity, and
existing disease (Table 1). Participants who reported any
vigorous PA demonstrated the lowest prevalence of
disease and risk factors.
Over an average follow-up of 7.8 years (median follow-
up, 8.5 years), there were 1,896 all-cause deaths (671
from CVD; 596 from cancer; 629 from other). There was
a dose–response association between PA and mortality
(Table 2), which persisted after adjustment for all
covariates, with the greatest survival beneﬁt being
observed in the vigorously active participants. However,
participating in mild-intensity PA was also associated
with a lower risk of all-cause mortality (hazard
ratio [HR]¼0.76, 95% CI¼0.69, 0.83); CVD mortality
(HR¼0.74, 95% CI¼0.65, 0.85); and death by other
causes (HR¼0.67, 95% CI¼0.58, 0.78). Only vigorous
PA was associated with lower risk of cancer mortality
(HR¼0.65, 95% CI¼0.52, 0.81).
In supplementary analyses using only baseline PA
exposure (Table S1), we observed a similar pattern of
results, although the effect estimates were generally
smaller and less robust with larger CIs. In furthersensitivity analyses (Table S2), the mild PA group was
assigned as the reference category. Interestingly, both
moderate and vigorous PA offered signiﬁcant protection
for all outcomes compared with mild PA, whereas
increased risk was observed in the inactive participants.
In further analyses, the sample was stratiﬁed according
to age into younger (o70 years) and older (Z70 years)
age groups. Again, robust dose–response associations
were observed for PA and survival in both age groups
(Tables 3 and 4), and the association between mild-
intensity PA and survival persisted.
In sensitivity analyses that excluded participants with
any mobility limitations at baseline (n=4,432), we
observed similar results to those of the main analyses:
HR for mild PA=0.72, 95% CI=0.56, 0.92; HR for
moderate PA=0.57, 95% CI=0.46, 0.70; and HR for
vigorous PA=0.50, 95% CI=0.39, 0.64.
Discussion
The aim of this study was to examine dose–response
associations between PA and survival over 8 years of
follow-up using a time-varying estimate of PA. The key
strength of this study was the use of a large representative
sample drawn from the community. We observed robust
dose–response associations between PA and survival,
even after adjusting for a wide range of sociodemo-
graphic and clinical risk factors. A key novel ﬁnding was
the association between mild-intensity “non-exercise”
PA and survival.
These results are consistent with recent data12,14 that
have also demonstrated beneﬁcial effects of light activity
on survival in older adults. Although causal associations
cannot be inferred from our data, longitudinal studies of
community samples have several advantages in that they
are more representative and can be followed over longer
periods of time without the risk of contamination effects,
which are a concern in controlled trials with extended
follow-up.
In the present study, we aimed to minimize possible
confounding by controlling for key covariables (includ-
ing age, gender, marital status, SEP, smoking, depressive
symptoms, and obesity) and reduce the risk of reverse
causality by adjusting for comorbidities. We have pre-
viously demonstrated associations between PA and
several biomarkers in ELSA,19 which supports the bio-
logical plausibility of our ﬁndings and further reinforces
the likelihood of causality.
A second aim of this study was to investigate the
effects of long-term PA exposure on survival, as previous
studies have generally relied on single measures taken at
baseline. Some previous studies7,13,14 have suggested that
an increase in PA during follow-up has beneﬁcial effectswww.ajpmonline.org
Table 1. Baseline characteristics of 10,426 women and men aged Z50 years, n (%) unless otherwise noted
Physical
inactivity
(n¼1,067)
Mild physical
activity
(n¼1,540)
Moderate physical
activity (n¼4,958)
Vigorous physical
activity (n¼2,861) p-valuea
Age (years; M [SD]) 71.0 (11.3) 68.3 (11.0) 64.6 (9.6) 61.7 (8.4) o0.001
Female 557 (52.2) 1,047 (68.0) 2,653 (54.0) 1,418 (49.6) o0.001
Married 584 (54.7) 868 (56.4) 3,416 (68.9) 2,096 (73.3) o0.001
University degree/a-level 157 (14.7) 239 (15.5) 1,426 (28.8) 1,125 (39.3) o0.001
Wealthiest tertile (Z£201,010) 191 (18.0) 296 (19.2) 1,731 (35.0) 1,264 (44.2) o0.001
Current smoker 210 (19.7) 343 (22.3) 914 (18.4) 377 (13.2) o0.001
BMI430b 274 (32.8) 446 (32.7) 1,165 (25.4) 519 (19.5) o0.001
Waist circumference Z102 cm
(in men)/88 cm (in women)b
406 (51.6) 605 (52.5) 1,627 (42.4) 742 (32.7) o0.001
Elevated depressive symptoms
(Z4 CES-D symptoms)
366 (34.3) 397 (25.8) 676 (13.6) 243 (8.5) o0.001
Heart disease 252 (24.0) 297 (19.3) 548 (11.1) 215 (8.0) o0.001
Stroke 135 (13.0) 94 (6.1) 161 (3.2) 53 (1.9) o0.001
Hypertension 509 (48.0) 724 (47.0) 1,872 (38.8) 867 (30.3) o0.001
Diabetes 138 (13.0) 176 (11.4) 340 (6.9) 122 (4.3) o0.001
Cancer 90 (8.4) 115 (7.5) 290 (5.8) 160 (5.6) o0.001
Psychiatric problems 84 (7.9) 137 (8.9) 358 (7.2) 198 (6.9) 0.090
COPD 147 (14.0) 158 (10.3) 288 (5.8) 96 (3.4) o0.001
Note: Boldface indicates signiﬁcance.
ap-values were generated using chi-square, Kruskal–Wallis, and ANOVA tests for categorical, ordinal, and continuous covariates, respectively.
bThe estimates of BMI and waist circumference were based on 9,463 and 8,041 individuals, respectively, with non-missing values.
CES-D, Centre of Epidemiological Studies Depression scale; COPD, chronic obstructive pulmonary disease.
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remaining sedentary is signiﬁcantly associated with
increased mortality risk in comparison with remaining
physically active.
A key strength of the present study was the availability
of repeated assessments of PA and other important
covariables such as chronic disease, enabling construc-
tion of a time-varying model. Consistent with a recent
study23 from the Framingham cohort, our data support
the notion that a single assessment of PA underestimates
the true effects, as we observed stronger, more robust
estimates in the time-varying model.
Mild “non-exercise” activities are generally deﬁned as
activity between 1.5 and 3 METs,24 such as housework
and light ambulatory activity, but an individual that only
participates in such activities would not currently meet
the PA guidelines. The protective effects of mild activity
that we have observed may be linked to the displacement
of sedentary time, as prolonged sitting may carry its own
health risks independent of PA.25,26October 2014Replacing 30 minutes per day of sedentary time with
equal amounts of mild PA was associated with better
physical health in a sample of older adults.27 This might
be biologically plausible but could also be explained by
differences in the perception of PA intensity28,29 in that
milder activities in older adults might actually elicit a
similar level of exertion to moderate activity in younger
participants. Given that the present PA guideline does
not appear to be achievable for the majority of older
adults, it would be desirable if older participants could
beneﬁt from incorporating milder PA into their daily
lives. Thus, our ﬁndings carry an important public health
message.
The pattern of association between PA and cancer
death was slightly different in that only vigorous activity
was deemed protective. This might be explained by the
fact we did not differentiate between speciﬁc types of
cancers, which is relevant as PA has been most consis-
tently associated with protection against breast, prostate,
and colon cancers.1
Table 2. Hazard ratios (95% CIs) for time-varying physical activity and survival in the overall sample (N¼10,426)
Cases (n) Person-years Model 1 Model 2 Model 3 Model 4 Model 5
All-cause mortality
Physical inactivity 466 6,959 1.00 1.00 1.00 1.00 1.00
Mild physical activity 449 11,236 0.54 (0.49, 0.59) 0.66 (0.61, 0.73) 0.72 (0.65, 0.78) 0.73 (0.67, 0.80) 0.76 (0.69, 0.83)
Moderate physical activity 742 39,408 0.25 (0.23, 0.27) 0.44 (0.40, 0.48) 0.47 (0.43, 0.51) 0.50 (0.46, 0.55) 0.54 (0.49, 0.59)
Vigorous physical activity 239 23,523 0.13 (0.12, 0.15) 0.34 (0.30, 0.38) 0.36 (0.32, 0.41) 0.40 (0.36, 0.45) 0.44 (0.39, 0.50)
p-value for linear trend o0.001 o0.001 o0.001 o0.001 o0.001
CVD mortality
Physical inactivity 190 6,959 1.00 1.00 1.00 1.00 1.00
Mild physical activity 173 11,236 0.49 (0.43, 0.57) 0.64 (0.55, 0.74) 0.69 (0.59, 0.79) 0.71 (0.61, 0.82) 0.74 (0.64, 0.85)
Moderate physical activity 229 39,408 0.19 (0.17, 0.22) 0.38 (0.33, 0.44) 0.41 (0.35, 0.47) 0.44 (0.41, 0.54) 0.48 (0.41, 0.55)
Vigorous physical activity 79 23,523 0.11 (0.09, 0.13) 0.34 (0.28, 0.42) 0.37 (0.31, 0.46) 0.42 (0.34, 0.51) 0.46 (0.38, 0.57)
p-value for linear trend o0.001 o0.001 o0.001 o0.001 o0.001
Cancer mortality
Physical inactivity 88 6,959 1.00 1.00 1.00 1.00 1.00
Mild physical activity 123 11,236 0.83 (0.69, 1.00) 0.94 (0.78, 1.13) 1.01 (0.84, 1.22) 1.02 (0.84, 1.23) 1.02 (0.85, 1.24)
Moderate physical activity 283 39,408 0.53 (0.45, 0.63) 0.76 (0.64, 0.90) 0.78 (0.65, 0.92) 0.82 (0.69, 0.98) 0.86 (0.72, 1.03)
Vigorous physical activity 102 23,852 0.32 (0.26, 0.39) 0.55 (0.45, 0.68) 0.55 (0.45, 0.68) 0.60 (0.48, 0.74) 0.65 (0.52, 0.81)
p-value for linear trend o0.001 o0.001 o0.001 o0.001 o0.001
Other mortality
Physical inactivity 188 6,959 1.00 1.00 1.00 1.00 1.00
Mild physical activity 153 11,236 0.45 (0.39, 0.52) 0.58 (0.51, 0.67) 0.63 (0.54, 0.73) 0.64 (0.55, 0.74) 0.67 (0.58, 0.78)
Moderate physical activity 230 39,408 0.17 (0.15, 0.20) 0.35 (0.30, 0.40) 0.37 (0.32, 0.43) 0.41 (0.35, 0.47) 0.44 (0.38, 0.51)
Vigorous physical activity 58 23,523 0.07 (0.06, 0.09) 0.23 (0.18, 0.29) 0.26 (0.20, 0.32) 0.29 (0.23, 0.36) 0.31 (0.25, 0.40)
p-value for linear trend o0.001 o0.001 o0.001 o0.001 o0.001
Note: Boldface indicates signiﬁcance. Model 1 is the unadjusted association. Model 2 is adjusted for age. Model 3 is additionally adjusted for gender, marital status, and socioeconomic position (total net
household wealth and education). Model 4 is additionally adjusted time-varying doctor-diagnosed self-reported chronic diseases (i.e., hypertension, diabetes, heart disease, stroke, cancer, psychiatric
problems, and chronic obstructive pulmonary disease). Model 5 is additionally adjusted the following time-varying covariates: elevated depressive symptoms, smoking, and obesity (BMI and waist
circumference).
CVD, cardiovascular disease.
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Table 3. Physical activity and survival in 7,008 women and men aged 50–69 years, HR (95% CI) unless otherwise noted
Cases (n)
Person-years of
follow-up Model 1 Model 2 Model 3 Model 4 Model 5
All-cause mortality
Physical inactivity 99 3,722 1.00 1.00 1.00 1.00 1.00
Mild physical activity 100 6,455 0.52 (0.42, 0.62) 0.55 (0.45, 0.67) 0.64 (0.53, 0.78) 0.68 (0.56, 0.82) 0.73 (0.60, 0.88)
Moderate physical activity 215 28,036 0.28 (0.24, 0.33) 0.31 (0.27, 0.37) 0.39 (0.33, 0.46) 0.44 (0.37, 0.53) 0.50 (0.42, 0.60)
Vigorous physical activity 102 19,292 0.18 (0.15, 0.22) 0.21 (0.17, 0.26) 0.27 (0.22, 0.33) 0.32 (0.26, 0.40) 0.38 (0.31, 0.47)
p-value for linear trend o0.001 o0.001 o0.001 o0.001 o0.001
CVD mortality
Physical inactivity 36 3,722 1.00 1.00 1.00 1.00 1.00
Mild physical activity 28 6,455 0.43 (0.30, 0.60) 0.46 (0.32, 0.65) 0.57 (0.40, 0.82) 0.62 (0.43, 0.88) 0.67 (0.47, 0.96)
Moderate physical activity 44 28,036 0.18 (0.13, 0.24) 0.20 (0.14, 0.27) 0.28 (0.21, 0.39) 0.35 (0.25, 0.49) 0.40 (0.29, 0.57)
Vigorous physical activity 20 19,292 0.10 (0.07, 0.16) 0.13 (0.08, 0.19) 0.20 (0.13, 0.30) 0.27 (0.18, 0.41) 0.32 (0.21, 0.50)
p-value for linear trend o0.001 o0.001 o0.001 o0.001 o0.001
Cancer mortality
Physical inactivity 27 3,722 1.00 1.00 1.00 1.00 1.00
Mild physical activity 42 6,455 0.78 (0.56, 1.09) 0.84 (0.60, 1.16) 0.91 (0.66, 1.28) 0.95 (0.68, 1.32) 0.99 (0.71, 1.39)
Moderate physical activity 127 28,036 0.58 (0.44, 0.77) 0.65 (0.49, 0.86) 0.70 (0.53, 0.94) 0.75 (0.56, 1.01) 0.83 (0.61, 1.12)
Vigorous physical activity 59 19,292 0.40 (0.29, 0.54) 0.46 (0.34, 0.63) 0.50 (0.37, 0.69) 0.55 (0.39, 0.76) 0.62 (0.45, 0.87)
p-value for linear trend o0.001 o0.001 o0.001 o0.001 0.001
Other mortality
Physical inactivity 36 3,722 1.00 1.00 1.00 1.00 1.00
Mild physical activity 30 6,455 0.40 (0.28, 0.55) 0.43 (0.31, 0.60) 0.51 (0.37, 0.72) 0.56 (0.40, 0.78) 0.62 (0.44, 0.87)
Moderate physical activity 44 28,036 0.15 (0.11, 0.20) 0.17 (0.13, 0.23) 0.23 (0.17, 0.31) 0.28 (0.20, 0.38) 0.32 (0.23, 0.44)
Vigorous physical activity 23 19,292 0.08 (0.06, 0.12) 0.10 (0.07, 0.14) 0.14 (0.09, 0.21) 0.19 (0.12, 0.28) 0.23 (0.15, 0.36)
p-value for linear trend o0.001 o0.001 o0.001 o0.001 o0.001
Note: Boldface indicates signiﬁcance. Model 1 is the unadjusted association. Model 2 is adjusted for age. Model 3 is adjusted for Model 2 and gender, marital status, and socioeconomic position (total
net household wealth and education). Model 4 is adjusted for Model 3 and time-varying doctor-diagnosed self-reported chronic diseases (i.e., hypertension, diabetes, heart disease, stroke, cancer,
psychiatric problems, and chronic obstructive pulmonary disease). Model 5 is adjusted for Model 4 and the following time-varying covariates: elevated depressive symptoms, smoking, and obesity (BMI
and waist circumference).
CVD, cardiovascular disease; HR, hazard ratio.
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Table 4. Physical activity and survival in 3,418 women and men aged Z70 years, HR (95% CI) unless otherwise noted
Cases (n) Person-years of follow-up Model 1 Model 2 Model 3 Model 4 Model 5
All-cause mortality
Physical inactivity 367 3,237 1.00 1.00 1.00 1.00 1.00
Mild physical activity 349 4,780 0.59 (0.53, 0.65) 0.68 (0.62, 0.76) 0.72 (0.66, 0.80) 0.74 (0.67, 0.82) 0.76 (0.69, 0.84)
Moderate physical activity 527 11,371 0.37 (0.33, 0.40) 0.48 (0.43, 0.53) 0.49 (0.44, 0.54) 0.52 (0.47, 0.57) 0.54 (0.49, 0.60)
Vigorous physical activity 137 4,231 0.29 (0.25, 0.33) 0.44 (0.38, 0.51) 0.43 (0.37, 0.50) 0.47 (0.40, 0.54) 0.50 (0.42, 0.58)
p-value for linear trend o0.001 o0.001 o0.001 o0.001 o0.001
CVD mortality
Physical inactivity 154 3,237 1.00 1.00 1.00 1.00 1.00
Mild physical activity 145 4,780 0.55 (0.47, 0.64) 0.66 (0.56, 0.77) 0.69 (0.59, 0.81) 0.71 (0.60, 0.83) 0.73 (0.62, 0.86)
Moderate physical activity 185 11,371 0.31 (0.27, 0.36) 0.43 (0.37, 0.50) 0.44 (0.37, 0.51) 0.46 (0.39, 0.54) 0.49 (0.42, 0.58)
Vigorous physical activity 59 4,231 0.30 (0.24, 0.37) 0.49 (0.39, 0.61) 0.48 (0.39, 0.61) 0.52 (0.41, 0.65) 0.56 (0.45, 0.71)
p-value for linear trend o0.001 o0.001 o0.001 o0.001 o0.001
Cancer mortality
Physical inactivity 61 3,237 1.00 1.00 1.00 1.00 1.00
Mild physical activity 81 4,780 0.91 (0.72, 1.14) 0.93 (0.74, 1.17) 1.00 (0.79, 1.25) 0.99 (0.78, 1.24) 1.00 (0.79, 1.26)
Moderate physical activity 156 11,371 0.72 (0.59, 0.89) 0.75 (0.61, 0.93) 0.74 (0.60, 0.91) 0.75 (0.62, 0.95) 0.81 (0.65, 1.01)
Vigorous physical activity 43 4,231 0.55 (0.41, 0.73) 0.58 (0.44, 0.78) 0.53 (0.40, 0.72) 0.57 (0.42, 0.77) 0.61 (0.45, 0.83)
p-value for linear trend o0.001 o0.001 o0.001 o0.001 o0.001
Other mortality
Physical inactivity 152 3,237 1.00 1.00 1.00 1.00 1.00
Mild physical activity 123 4,780 0.50 (0.43, 0.59) 0.62 (0.53, 0.73) 0.66 (0.56, 0.77) 0.66 (0.56, 0.78) 0.69 (0.58, 0.81)
Moderate physical activity 186 11,371 0.29 (0.25, 0.33) 0.41 (0.35, 0.48) 0.43 (0.36, 0.50) 0.46 (0.39, 0.54) 0.48 (0.41, 0.57)
Vigorous physical activity 35 4,231 0.18 (0.14, 0.24) 0.33 (0.25, 0.43) 0.34 (0.26, 0.45) 0.37 (0.28, 0.49) 0.38 (0.29, 0.50)
p-value for linear trend o0.001 o0.001 o0.001 o0.001 o0.001
Note: Boldface indicates signiﬁcance. Model 1 is the unadjusted association. Model 2 is adjusted for age. Model 3 is adjusted for Model 2 and gender, marital status, and socioeconomic position (total
net household wealth and education). Model 4 is adjusted for Model 3 and time-varying doctor-diagnosed self-reported chronic diseases (i.e., hypertension, diabetes, heart disease, stroke, cancer,
psychiatric problems, and chronic obstructive pulmonary disease). Model 5 is adjusted for Model 4 and the following time-varying covariates: elevated depressive symptoms, smoking, and obesity (BMI
and waist circumference).
CVD, cardiovascular disease; HR, hazard ratio.
H
am
er
et
al/
A
m
J
Prev
M
ed
2014;47(4):452
–460
458
w
w
w
.ajpm
online.org
Hamer et al / Am J Prev Med 2014;47(4):452–460 459Our study has some limitations. Chronic disease was
based on self-report of physician diagnosis, although
previous work30 has demonstrated the validity of this
measure in ELSA. Self-reported PA was crudely assessed,
albeit the same questions were consistently used at each
follow-up assessment. For this reason, and because self-
reported PA in older adults has been shown to over-
estimate actual activity and underestimate its true effects
on mortality in older adults,15 our study may have
considerably underestimated the strength of associations
between PA and survival.
Because the physical activity questionnaire was rela-
tively crude and did not inquire about PA time, but only
frequency, it was challenging to derive any meaningful
data on “volume.” However, our data suggest that the
vigorously active participants did in fact record the
greatest volume of activity, as 84.2% and 79.1% of this
group also recorded mild or moderate activity, respec-
tively, more than once a week.
Thus, the greater beneﬁts seen in the vigorous PA
group may, in part, have been derived from a higher total
volume of PA. The interpretation of HR estimates in the
presence of time-dependent covariates is potentially
more complex than its non–time-dependent counterpart,
although our results were comparable using the different
approaches.
In summary, we observed robust, multivariate-adjusted
dose–response associations between time-varying PA and
survival in a large representative sample of community-
dwelling older adults over 10 years of follow-up. A
key novel ﬁnding was the association between mild-
intensity PA and survival. These data suggest that
optimal health beneﬁts can be achieved through more
vigorous–intensity PA. Older adults may also gain
survival beneﬁt from participation in lower-intensity
activity that is below the threshold set by the present
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